ArticleMolecular medicine (Cambridge, Mass.)2016

TCRγ4δ1-engineered αβT cells exhibit effective antitumor activity.

Kangxia He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.